Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (141-150 of 560) with videos related to

Pageof 56
Sort By:
The Prostate|October 25, 2016
Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized MedicinePaolo Capogrosso, Eugenio Ventimiglia, Marco Moschini, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 17, 2020
Biomarkers predicting oncological outcomes of high-risk non-muscle-invasive bladder cancerLuca Afferi, Marco Moschini, Marcus G Cumberbatch, et al.
Journal of Endourology|June 24, 2015
The Value of Open Conversion Simulations During Robot-Assisted Radical Prostatectomy: Implications for Robotic Training CurriculaFabio Zattoni, Andrea Guttilla, Alessandro Crestani, et al.
European Urology|January 11, 2016
The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer PatientsLorenzo Bianchi, Alessandro Nini, Marco Bianchi, et al.
Journal of Endourology|June 14, 2021
The Management of Distal Ureter During Radical Nephroureterectomy Does Not Influence Bladder RecurrenceMarina Pizzighella, Franck Bruyère, Benoit Peyronnet, et al.
World Journal of Urology|January 26, 2018
Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapyMarco Moschini, Agostino Mattei, Julian Cornelius, et al.
European Urology Focus|June 14, 2020
Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant TherapiesFrancesco Soria, David D'Andrea, Mohammad Abufaraj, et al.
Journal of Endourology|April 28, 2020
The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-AnalysisWojciech Krajewski, Łukasz Nowak, Sławomir Poletajew, et al.
BJU International|June 21, 2019
Long-term functional and oncological outcomes of nerve-sparing and prostate capsule-sparing cystectomy: a single-centre experienceMohamed Saad, Marco Moschini, Armando Stabile, et al.
Urology|April 26, 2017
Diagnostic Accuracy of <sup>64</sup>Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary ExperienceFrancesco Cantiello, Vincenzo Gangemi, Giuseppe Lucio Cascini, et al.
Pageof 56

Showing results (141-150 of 560) with videos related to

Sort By:
Pageof 56
The Prostate|October 25, 2016
Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized MedicinePaolo Capogrosso, Eugenio Ventimiglia, Marco Moschini, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 17, 2020
Biomarkers predicting oncological outcomes of high-risk non-muscle-invasive bladder cancerLuca Afferi, Marco Moschini, Marcus G Cumberbatch, et al.
Journal of Endourology|June 24, 2015
The Value of Open Conversion Simulations During Robot-Assisted Radical Prostatectomy: Implications for Robotic Training CurriculaFabio Zattoni, Andrea Guttilla, Alessandro Crestani, et al.
European Urology|January 11, 2016
The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer PatientsLorenzo Bianchi, Alessandro Nini, Marco Bianchi, et al.
Journal of Endourology|June 14, 2021
The Management of Distal Ureter During Radical Nephroureterectomy Does Not Influence Bladder RecurrenceMarina Pizzighella, Franck Bruyère, Benoit Peyronnet, et al.
World Journal of Urology|January 26, 2018
Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapyMarco Moschini, Agostino Mattei, Julian Cornelius, et al.
European Urology Focus|June 14, 2020
Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant TherapiesFrancesco Soria, David D'Andrea, Mohammad Abufaraj, et al.
Journal of Endourology|April 28, 2020
The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-AnalysisWojciech Krajewski, Łukasz Nowak, Sławomir Poletajew, et al.
BJU International|June 21, 2019
Long-term functional and oncological outcomes of nerve-sparing and prostate capsule-sparing cystectomy: a single-centre experienceMohamed Saad, Marco Moschini, Armando Stabile, et al.
Urology|April 26, 2017
Diagnostic Accuracy of <sup>64</sup>Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary ExperienceFrancesco Cantiello, Vincenzo Gangemi, Giuseppe Lucio Cascini, et al.
Pageof 56